SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Regeneron Pharmaceuticals
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
3557 104 0 REGN
Emcee:  Patrick Slevin Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2982If ego was the takeaway, that's really missing the point. I am seeing clearCuttingEdge Bio-6/3/2020
2981There are too many warts on the existing developing hemo geneTx treatments, thatCuttingEdge Bio16/3/2020
2980Looks like Lily is first in clinic with a mAb\ statnews.comFelix B-6/2/2020
2979Tidbit, mITT NSCLC OS (FDA approved PDL1 test, N= 563, from N=712), slide 18: HRMiljenko Zuanic16/1/2020
2978REGN at ASCO20: edge.media-server.com Good listening, with several points of EGMiljenko Zuanic-6/1/2020
2977<Can hemophilia-A and -B markets support so many players? Is this a winner-taMiljenko Zuanic-6/1/2020
2976Can hemophilia-A and -B markets support so many players? Is this a winner-take-aDewDiligence_on_SI-6/1/2020
2975REGN and NTLA Doubt very much that CRISPR/Cas9-based therapeutic is a way to go Miljenko Zuanic-6/1/2020
2974ASCO2020 data and Yan will give REGN general oncology update/perspective. More dMiljenko Zuanic-5/28/2020
2973I haven't been following Onc, what data will be released during those dates?Felix B-5/28/2020
2972Well yesterday I felt pretty stupid, Topped up at $540 may 26 and then didn’t pBiotechwantabe-5/28/2020
2971In two days Sanofi left on table $ 1.2B (worth in REGN stock)! Not bad at all. Miljenko Zuanic-5/28/2020
2970Yes, agree. Idea is to show how underwriter (one of them) make money, by promotiMiljenko Zuanic-5/26/2020
2969I never pay much attention to those analyst predictions, worse creditability thaFelix B-5/26/2020
2968Offer is at $515/share. So, Citi target price of 734 (at the time they announceMiljenko Zuanic-5/26/2020
2967Also, I would guess Sanofi is building cash for some *smaller* acquisition targeMiljenko Zuanic-5/25/2020
2966Routine portfolio housecleaning by SNY based on valuation. No particular signifiDewDiligence_on_SI-5/25/2020
2965Any significance of this or just part of SNY getting rid of their REGN shares?Felix B-5/25/2020
2964REGN’s purchasing $5B worth of stock (~9M shares) directly from SNY at the sameDewDiligence_on_SI-5/25/2020
2963investor.regeneron.com Secondary offering and sale.Biotechwantabe-5/25/2020
2962That is a concern indeed....I am curious what animals they have tested this in? Felix B-5/19/2020
2961And second week of June into clinic. Right on the 5-month mark from early JanuaCuttingEdge Bio-5/19/2020
2960Well I dunno if they will test in marmosets, but that was considered the toughesCuttingEdge Bio-5/19/2020
2959RBC cc today, Bob mentioned COVID antibody cocktail, REGN-COV2, primate study (oMiljenko Zuanic-5/19/2020
2958So, lesson is, don’t jump to any conclusions until we see marmoset data.Biotechwantabe-5/19/2020
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News